Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvalent Inc NUVL

Nuvalent, Inc. is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer. It develops small molecules that have the potential to overcome resistance, minimize adverse events, address brain metastases and drive more durable responses. It is advancing a robust pipeline with investigational candidates for ROS1-positive, ALK-positive, and HER2-positive non-small cell lung cancer, and multiple discovery-stage research programs. Its product candidate, NVL-520, is being developed for patients with ROS proto-oncogene 1 (ROS1)-positive non-small cell lung cancer (NSCLC). NVL-520 is a novel ROS1-selective inhibitor. Its product candidate, NVL-655, is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC. LC. NVL-655 is a brain-penetrant ALK-selective inhibitor. Its product candidate, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor.


NDAQ:NUVL - Post by User

<< Previous
Bullboard Posts
Next >>
Post by metmron Feb 22, 2001 3:57pm
137 Views
Post# 3369606

Harmony and Nixxo

Harmony and Nixxoeiger technology (AXA) is playing a major part in all of this. Best thing I can suggest is for those interested to go to SEDAR and print/read all of the postings and releases from AXA for about the last 12 months. In a nut shell IMHO this is as it stands now. Eiger owns 25% of Nixxo. Nixxo is a subsidiary of Standard Telecom America (STA). STA is a divission of Standard Telecon Korea STA. STA has over $500 million in sales/ year. Eiger announced that Nixxo and Harmony will merge and after the merger will be known as Nixxo. IMHO Eiger was the force behind this merger. I and several Eiger posters believed at that time that is was a faster way for Eiger to get listed in the US. This has been confirmed to a point by the latest release from Eiger dealing with their purchase of 55% of STA for 7 million Eiger shares and a removal of the condition that Nixxo be listed on a stock exchange. I guess that a US listing is not as important at this time. Where this leaves Harmony I am not sure because I was under the impression that the Nixxo and Harmony merger was completed. However there is no mention of this in Eiger's latest release. After the latest Eiger/STA deal is completed the Nixxo products will be known as Nixxo by Eiger technology. One thing for certain is that the Eiger team can and do make some great deals and IMHO are positioning themselves well for the future of MP3 and DSL and wireless internet/cellphones. good luck with your DD
<< Previous
Bullboard Posts
Next >>